Aarey Drugs Pharmaceuticals Ltd vs Cipla Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 88.98 as of 18 May 13:45 . The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Cipla Ltd changed from 27.3 on March 2021 to 22.1 on March 2025 . This represents a CAGR of -4.14% over 5 years The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Cipla Ltd changed from ₹ 65746 crore on March 2021 to ₹ 116434 crore on March 2025 . This represents a CAGR of 12.11% over 5 years The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Cipla Ltd for the Mar '26 is ₹ 6689 crore as compare to the Dec '25 revenue of ₹ 7280 crore. This represent the decline of -8.12% The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Cipla Ltd for the Mar '26 is ₹ 1103 crore as compare to the Dec '25 ebitda of ₹ 1185 crore. This represent the decline of -6.95% The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Cipla Ltd changed from ₹ 1176 crore to ₹ 550.11 crore over 8 quarters. This represents a CAGR of -31.61% The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Cipla Ltd changed from 16.34 % on March 2021 to 25.05 % on March 2025 . This represents a CAGR of 8.92% over 5 years .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited.
The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the Company and it was converted into public limited company.
Also, the name of the company was changed from Niharika Textiles & Chemicals Private Limited to Aarey Drugs & Pharmaceuticals Limited. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Cipla Ltd

Cipla Limited is one of the leading pharmaceutical companies in India.
The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'.

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Cipla Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Cipla Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 258 Cr while Market cap of Cipla Ltd is 115,640 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Cipla Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Cipla Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Cipla Ltd?

As of May 18, 2026, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹90.99. On the other hand, Cipla Ltd stock price is INR ₹1431.55.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Cipla Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Cipla Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.